SCHEMBL7209341

SCHEMBL7209341

O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Br)ccc1NS(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC20A2 Q08357 1/20 0.62
SLC20A1 Q8WUM9 1/20 0.62
SLC10A6 Q3KNW5 2/20 0.58
SLC10A2 Q12908 1/20 0.58
SLC10A1 Q14973 1/20 0.58
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
GAA P10253 1/20 0.52
AVPR2 P30518 2/20 0.48
GPR27 Q9NS67 2/20 0.48
KDM1A O60341 1/20 0.48
CCR2 P41597 1/20 0.48
OPRK1 P41145 1/20 0.46
HTT P42858 1/20 0.46
ALPL P05186 1/20 0.46
RXFP1 Q9HBX9 3/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
ACLY P53396 1/20 0.46
MCL1 Q07820 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128725 0.90 SLC20A2 (0.66) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL7213029 0.90 SLC20A2 (0.60) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL28454669 0.88 MEN1 (0.64) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL5117189 0.85 SLC10A6 (0.72) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL5598179 0.82 SLC10A6 (0.59) SLC10A6SLC10A2SLC10A1MEN1KMT2A
SCHEMBL7118571 0.80 SLC10A6 (0.85) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL7627121 0.79 SLC10A6 (0.71) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL7213034 0.79 MEN1 (0.57) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL7120286 0.78 SLC20A2 (0.74) SLC20A2SLC20A1SLC10A6SLC10A2SLC10A1
SCHEMBL27180121 0.77 MCL1 (0.66) SLC20A2SLC20A1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP disclosed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO disclosed